Defusing the global timebomb

Journal of Public Health Policy

Volumn 26, Issue 1, 2005, Pages 115-121

  Reichman, Lee B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL TRANSMISSION; COST EFFECTIVENESS ANALYSIS; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LONG TERM CARE; MULTIDRUG RESISTANCE; NOTE; PUBLIC HEALTH SERVICE; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

DIRECTLY OBSERVED THERAPY; DISEASE OUTBREAKS; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 18244382296     PISSN: 01975897     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jphp.3200005     Document Type: Note

References (24)

1. Comstock G, Cauthen G. Epidemiology of tuberculosis. In: Reichman LB, Hershfield E, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, 1993; pp. 23-48.
2. Starke JR, Jacobs RF, Jareb T. Resurgence of tuberculosis in children. J Pediatr. 1992;120:838-55.
3. Snider Jr DE, Roper W. The new tuberculosis. N Engl J Med. 1992;328:703-5.
4. Reichman LB. The U shaped curve of concern. Am Rev Respir Dis. 1991;148:741-2.
5. US Congress. Office of Technology Assessment. The continuing challenge of tuberculosis. Washington, DC: US Congress, Office of Technology Assessment; September 1993. Document OTA-H-574.
6. Centers for Disease Control. National action plan to combat multidrug resistant tuberculosis. MMWR. 1992;41(RR-11):1-48.
7. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274:945-51.
8. Moulding J, Dutt AK, Reichman LB. Fixed dose combination of antituberculosis medications to prevent drug resistance. Ann Intern Med. 1995;122:951-4.
9. Mangura BT, Napolitano E, Passannante MR, Sarrel M, Glanowsky K, McDonald RJ, Reichman LB. DOT is not the entire answer. An operational cohort analysis. Int J Tuberc Lung Dis. 2002;6(8):1-8.
10. Reichman LB. The national tuberculosis training initiative. Ann Intern Med. 1989;111:197-8.
11. Yeager Jr H, Medinger AE. Tuberculosis long-term beds: have we thrown the baby out with the bath water? Chest. 1986;90:752-4.
12. Centers for Disease Control. Outbreak of multidrug resistant tuberculosis - Texas, California and Pennsylvania. MMWR. 1990;39:369-372.
13. Lambregts-van Weezenbeek KSB, Reichman LB. DOTS and DOTS-Plus: what's in a name. Int J Tuberc Lung Dis. 2000;4(11):995-6.
14. Etkind SC. Contact tracing in tuberculosis. In: Reichman LB, Hershfield E, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, 1993; pp. 275-89.
15. Rouillon A. "Defaulters" and "Motivation". Bull Int Union Tuberc. 1972;47:68-73.
16. Reichman LB. Tuberculosis elimination-what's to stop us? Int J Tuberc Lung Dis. 1997;1:3-11.
17. Uplekar MW, Shepard DS. Treatment of tuberculosis by private general practitioners in India. Tubercle. 1991;72:284-90.
18. Sumartojo E, Hale BE, Geiter L. Physician practices in preventing and treating tuberculosis: results of a national survey. Am Rev Respir Dis. 1993;147:A702.
19. Byrd RB, Horn BR, Solomon D, Griggs GA, Wilder NJ. Treatment of tuberculosis by the nonpulmonary physician. Ann Intern Med. 1977;86:799-802.
20. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA. 1993;70:65-8.
21. Sbarbaro JA. Editorial: a challenge to our practices and to our principles. Tubercle Lung Dis. 1996;77:2-3.
22. Reichman LB. Editorial: the U-shaped curve of concern. Am Rev Respir Dis. 1991;144:741-2.
23. Reichman LB, Tanne JH. TIMEBOMB: The Global Epidemic of Multidrug Resistant Tuberculosis. New York: McGraw-Hill, 2002.
24. Atre SR, Mistry NF. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants. J Pub Hlth Policy. 2005;26:96-114.